Dowsett, Joseph http://orcid.org/0000-0001-5381-2633
Ferkingstad, Egil http://orcid.org/0000-0001-8090-7988
Rasmussen, Line Jee Hartmann
Thørner, Lise Wegner
Magnússon, Magnús K. http://orcid.org/0000-0001-8593-4934
Sugden, Karen
Thorleifsson, Gudmar
Frigge, Mike http://orcid.org/0000-0003-2984-535X
Burgdorf, Kristoffer Sølvsten
Ostrowski, Sisse Rye http://orcid.org/0000-0001-5288-3851
Sørensen, Erik
Erikstrup, Christian http://orcid.org/0000-0001-6551-6647
Pedersen, Ole Birger http://orcid.org/0000-0003-2312-5976
Hansen, Thomas Folkmann http://orcid.org/0000-0001-6703-7762
Banasik, Karina http://orcid.org/0000-0003-2489-2499
Brunak, Søren http://orcid.org/0000-0003-0316-5866
Andersen, Steffen
Jemec, Gregor
Jennum, Poul
Nielsen, Rene Kasper
Nyegaard, Mette
Paarup, Helene Martina
Petersen, Mikkel
Werge, Thomas
Gudbjartsson, Daniel
Stefansson, Kari
Þorsteinsdóttir, Unnur
Tragante, Vinicius http://orcid.org/0000-0002-8223-8957
Lund, Sigrun Helga http://orcid.org/0000-0002-3806-2296
Stefansdottir, Lilja
Gunnarson, Bjarni
Poulton, Richie http://orcid.org/0000-0002-1052-4583
Arseneault, Louise http://orcid.org/0000-0002-2938-2191
Caspi, Avshalom
Moffitt, Terrie E.
Gudbjartsson, Daníel http://orcid.org/0000-0002-5222-9857
Eugen-Olsen, Jesper
Stefánsson, Hreinn
Stefánsson, Kári http://orcid.org/0000-0003-1676-864X
Ullum, Henrik
,
,
,
Funding for this research was provided by:
Det Frie Forskningsråd (09-069412, 0602-02634B)
Aase og Ejnar Danielsens Fond
Novo Nordisk Fonden (NNF17OC0027594, NNF14CC0001, NNF17OC0027594, NNF14CC0001, NNF17OC0027594)
The Danish Regions
Lundbeckfonden (R288-2018-380)
The Innovative Medicines Initiative 2 Joint Undertaking
Innovationsfonden
Article History
Received: 7 August 2020
Accepted: 23 April 2021
First Online: 2 June 2021
Competing interests
: The authors E.F., G.T., M.F., M.K.M., V.T., S.H.L., L.S., B.G., D.G., H.S., and K. Stefánsson who are affiliated with deCODE genetics/AMGEN, declare competing interests as employees. J.E.O. is named inventor on patents on suPAR owned by Copenhagen University Hospital Hvidovre, Denmark. J.E.O. is co-founder, shareholder, and board member of ViroGates A/S, Denmark, the company that developed the suPARnostic ELISA. ViroGates A/S had no role in the study design, data collection, analysis, or interpretation of study findings, and/or in the decision to submit the manuscript for publication. The remaining authors declare no competing interests.